HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 85 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $255,058 | -36.9% | 4,629 | -49.3% | 0.02% | -43.3% |
| Q3 2022 | $404,000 | -54.3% | 9,129 | -49.6% | 0.03% | -51.6% |
| Q2 2022 | $884,000 | +0.2% | 18,129 | 0.0% | 0.06% | +21.6% |
| Q1 2022 | $882,000 | +14.1% | 18,129 | 0.0% | 0.05% | +8.5% |
| Q4 2021 | $773,000 | -44.2% | 18,129 | -49.8% | 0.05% | -48.9% |
| Q3 2021 | $1,385,000 | +38.6% | 36,129 | +2.1% | 0.09% | +37.3% |
| Q2 2021 | $999,000 | – | 35,383 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |